Live Breaking News & Updates on Primary Biliary Cholangitis

Stay updated with breaking news from Primary biliary cholangitis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Science 37 Surpasses Enrollment Goals, Accelerates Phase 2 Rare Disease Clinical Trial

Science 37 Enrolls 21% of Study Participants at 11x the Speed of Traditional Research Sites Through its Virtual Site and Patient Recruitment Solutions RESEARCH… ....

Erica-prowisor , Provider-networks-at-science , Holdings-inc , Speed-of-traditional-research-sites , Patient-recruitment-solutions , Study-participants , Traditional-research-sites-through , Virtual-site , Patient-recruitment , Cholestatic-pruritus , Primary-biliary-cholangitis , Primary-sclerosing

GENFIT: Historic Milestone Achieved with U.S. FDA Accelerated Approval of Ipsen's Iqirvo® for Primary Biliary Cholangitis | 10.06.24

GENFIT: Historic Milestone Achieved with U.S. FDA Accelerated Approval of Ipsen's Iqirvo® for Primary Biliary Cholangitis | 10.06.24
finanzen.at - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanzen.at Daily Mail and Mail on Sunday newspapers.

Taiwan , Massachusetts , United-states , China , United-kingdom , Macau , Switzerland , Cambridge , Cambridgeshire , Paris , France-general , France

Ipsen's Iqirvo® receives U.S. FDA accelerated approval as a first-in-class PPAR treatment for primary biliary cholangitis | Company Announcement

Ipsen's Iqirvo® receives U.S. FDA accelerated approval as a first-in-class PPAR treatment for primary biliary cholangitis | Company Announcement
investegate.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investegate.co.uk Daily Mail and Mail on Sunday newspapers.

United-states , Macau , Paris , France-general , France , United-kingdom , China , Hong-kong , Washington , Taiwan , American , Ipsen-euronext

Ipsen Pharma: Ipsen's Iqirvo® receives U.S. FDA accelerated approval as a first-in-class PPAR treatment for primary biliary cholangitis

Iqirvo® (elafibranor) 80 mg tablets is the first new medicine approved in nearly a decade for the treatment of the rare liver ....

Paris , France-general , France , Macau , United-states , China , United-kingdom , Washington , Hong-kong , Taiwan , American , Christelle-huguet

Ipsen's Iqirvo® receives U.S. FDA accelerated approval as a

Ipsen's Iqirvo® receives U.S. FDA accelerated approval as a
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

Taiwan , Paris , France-general , France , United-states , Hong-kong , Washington , China , United-kingdom , Macau , American , Carol-roberts